prescription-only strength of the allergy drug Reactine

Pfizer is launching a prescription-only strength of the allergy drug Reactine.

The new tablets contain 20 mg of the "low sedating" antihistamine cetirizine.

The 20 mg strength was originally approved back in 1991 as an Rx drug...Pfizer has finally gotten around to marketing it.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote